Stoke Therapeutics, Inc. financial data

Symbol
STOK on Nasdaq
Location
45 Wiggins Avenue, Bedford, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 697 % +16.8%
Debt-to-equity 16.5 % -50.9%
Return On Equity 13.3 %
Return On Assets 11.4 %
Operating Margin 13.2 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.1M shares +7.84%
Common Stock, Shares, Outstanding 55.1M shares +4.12%
Entity Public Float 528M USD +82.1%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 58.6M shares +4.03%
Weighted Average Number of Shares Outstanding, Diluted 58.6M shares +4.03%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 206M USD +1128%
Research and Development Expense 120M USD +36.8%
General and Administrative Expense 55.5M USD +25.6%
Operating Income (Loss) 27.2M USD -43.6%
Nonoperating Income (Expense) 13.4M USD +12.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -39.6M USD -49.9%
Income Tax Expense (Benefit) -1.28M USD
Net Income (Loss) Attributable to Parent 40.6M USD -45.1%
Earnings Per Share, Basic 0 USD/shares -38.3%
Earnings Per Share, Diluted 0 USD/shares -38.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.4M USD -44.4%
Accounts Receivable, after Allowance for Credit Loss, Current 9.25M USD
Other Assets, Current 5.54M USD +45.5%
Assets, Current 272M USD +7.42%
Property, Plant and Equipment, Net 3.08M USD -28.8%
Operating Lease, Right-of-Use Asset 3.71M USD -24.8%
Assets 360M USD +22.8%
Accounts Payable, Current 5.87M USD +136%
Liabilities, Current 41.7M USD -16.3%
Operating Lease, Liability, Noncurrent 1.87M USD -37.7%
Other Liabilities, Noncurrent 1.87M USD -38.6%
Liabilities 52.2M USD -14.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 446K USD +169%
Retained Earnings (Accumulated Deficit) -440M USD +8.45%
Stockholders' Equity Attributable to Parent 308M USD +32.7%
Liabilities and Equity 360M USD +22.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 132M USD
Net Cash Provided by (Used in) Financing Activities 1.37M USD -20%
Net Cash Provided by (Used in) Investing Activities 13.6M USD +36.5%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 55.1M shares +4.12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 147M USD
Deferred Tax Assets, Valuation Allowance 166M USD +24.2%
Deferred Tax Assets, Gross 166M USD +24.2%
Operating Lease, Liability 4.78M USD -9.88%
Depreciation 477K USD -15.3%
Payments to Acquire Property, Plant, and Equipment 152K USD +1167%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 40.8M USD -44.8%
Lessee, Operating Lease, Liability, to be Paid 5.2M USD -11.5%
Property, Plant and Equipment, Gross 12.8M USD +2.11%
Operating Lease, Liability, Current 2.91M USD +26.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.25M USD +22.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 780K USD +19.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 422K USD -26.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 701K USD -72.7%
Deferred Tax Assets, Operating Loss Carryforwards 70.1M USD +33.2%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 473K USD
Additional Paid in Capital 747M USD +4.93%
Share-based Payment Arrangement, Expense 29.5M USD +11.9%
Interest Expense 6K USD